Utilitzem cookies pròpies i de tercers per millorar els nostres serveis i mostra-te publicitat relacionada emb les teves preferències mitjançant l'anàlisis dels teus hàbits de navegació. Si segueixes navegant, considerem que acceptes el seu ús. Pots canviar la teva configuració o obtenir més informació a la nostra Política de Cookies. Clica a ACCEPTAR per confirmar que has llegit i acceptat aquesta informació. Després d'acceptar-la no tornarem a mostrar aquest maissatge.
Retinoblastoma online Questions & Answers – Clinical and research experts from SJD Barcelona Children's Hospital
Publicat el 26 Apr 21
Your opinion is very important for us. If you had the opportunity to attend the event, or you have already seen this video, please, fill out the questionnaire to help us to improve for next events.
- Opening remarks. Mrs Chenna Zhang, patient manager at SJD Barcelona Children's Hospital.
- Dr Jaume Català-Mora, pediatric ophthalmologist at SJD Barcelona Children's Hospital. Current treatment protocol for globe salvage in retinoblastoma.
- Dr Guillermo Chantada, oncologist and hematologist at SJD Barcelona Children's Hospital. Innovative treatments for retinoblastoma.
- Dr Ángel Montero Carcaboso, researcher group leader at SJD Barcelona Children's Hospital. Treatment of retinoblastoma with the oncolytic adenovirus VCN-01: scientific basis and first clinical experience.
- Session closing.
Pediatric ophthalmologist. Expert in anterior and posterior Segment Surgery. Clinical and medical retina. Retina surgical and vitreous.
- Observership Devers Eye Institute. Portland, Oregon (USA), 2007.
- Observership Casey Eye Institute, Oregon Health and Science University (OHSU) (USA), 2007.
- Observership Moorfields Eye Hospital, London (United Kindom), 2002.
- Ophthalmologist Rotation, Centre Hospitalier Toulouse-Rangell (France), 1995.
Author of over 70 national and international papers in conferences and numerous articles published in national and international specialized scientific journals.
Oncologist and hematologist. Expert in pediatric oncology.
- Specialist at the Hemato-Oncology Service, JP Garrahan Pediatric Hospital, Buenos Aires (Argentina).
- Pediatric Hemato-Oncology Service, Memorial Sloan-Kettering Cancer Center, New York (USA), 1995.
- Hematology Service, Hannover Medical School (Medizinische Hochschule Hannover – MHH) (Germany), 1999.
- Grant, Fund for Ophthalmic Knowledge (New York, USA) for a two-month research rotation at the Memorial Sloan Kettering Cancer Center and the New York Presbyterian Hospital, November 2002
He has participated in many national and international conferences and congresses and been awarded numerous prizes. Reviewer of scientific articles for internationally acknowledged medical publications. Author of numerous publications, including book chapters and over 60 papers in international journals with references available at PubMed. He has taken part in a number of research studies as lead researcher: clinical research protocols and translational research protocols.
ÁNGEL MONTERO CARCABOSO
Researcher group leader. Expert in Therapy Development in Pediatric Oncology.
Dr Carcaboso holds a wide pharmaceutical background. He has performed multidisciplinary and translational work in the field of pediatric oncology. He has shown, together with his colleagues at SJD and his former institutions, success to develop innovative projects, even advanced therapies, for children with cancer. They have achieved clinical trials and international acknowledgement of their work.